Refractory Form of Chronic Idiopathic Demyelinating Polyneuropathy with Rituximab Effect: A Case Report

Area of Science:

• Neurology
• Immunology
• Pathophysiology of Neurological Disorders

Background:

• Chronic idiopathic demyelinating polyneuropathy (CIDP) is an autoimmune disorder characterized by peripheral nerve demyelination.
• Pathogenesis involves antibodies against myelin proteins and cell-mediated immunity with T-cell and macrophage infiltration.
• Standard treatments aim to suppress inflammation and remove pathogenic molecules, including corticosteroids, immunoglobulins, and plasma exchange.

Purpose of the Study:

• To present a case of refractory CIDP.
• To discuss the management challenges and current knowledge regarding refractory CIDP.
• To highlight the significance of severe neurological findings in refractory CIDP.

Main Methods:

• Case report presentation.
• Review of current literature on CIDP and refractory CIDP.
• Discussion of treatment modalities and diagnostic criteria.

Main Results:

• The presented patient exhibited severe neurological findings.
• The patient showed a lack of clinical response to standard CIDP treatments (corticosteroids, immunoglobulins, plasmapheresis).
• The condition was diagnosed as refractory CIDP, affecting up to 10% of CIDP patients.

Conclusions:

• Refractory CIDP presents a significant clinical challenge.
• Understanding refractory CIDP is crucial for managing patients unresponsive to established therapies.
• Further research into alternative treatment strategies for refractory CIDP is warranted.